 BOSTON, Aug. 31, 2022 GLOBE NEWSWIRE -- Decibel Therapeutics Nasdaq: DBTX, a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that Laurence Reid, Ph.D., Chief Executive Officer, will be participating in the following upcoming investor conferences in September. 